ABILIFY
Swiss trademark · 503917 · Word mark · In force
Register entry
- Registration number
- 503917
- Application number
- 07195/2002
- Status
- In force
- Type
- Word mark
- Filed
- Aug 20, 2002
- Registered
- Oct 9, 2002
- Published
- Oct 23, 2002
- Protected until
- Aug 20, 2032
- Priority
- 13.06.2002 US
- Language of procedure
- German
- Source
- Swissreg
Goods and services
Pharmaceuticals
Pharmazeutische Präparate für die Behandlung und Vorbeugung von Herz- und Gefässkrankheiten, Krankheiten und Störungen des Zentralnervensystems, Schlaganfall, Krebs, Entzündungs- und entzündlichen Krankheiten, Atmungs- und Infektionskrankheiten, Autoimmunkrankheiten, Antibiotika.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 27, 2022
Agent removed
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich (removed)
Published in Swissreg on 27.07.2022
- Jul 27, 2022
Agent entered
- Representative
- RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich
Published in Swissreg on 27.07.2022
- Jul 27, 2022
Renewed
Published in Swissreg on 27.07.2022
- Jul 4, 2012
Renewed
Published in Swissreg on 04.07.2012
- Apr 10, 2007
Transferred
- Owner
- Bristol-Myers Squibb Company, 345 Park Avenue, New York (NY 10154), USA → Otsuka Pharmaceutical Co., Ltd., 2-9 Kanda Tsukasa-cho,, Chiyoda-ku, Tokyo 101-8535, Japan
- Representative
- E. Blum & Co., Patentanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich
Published in the SOGC no. 68 of 10.04.2007
- Oct 23, 2002
Registered
Published in the SOGC no. 205 of 23.10.2002
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.